State can expect windfall with Malin planning sale of shares in key assets
Malin, the listed life sciences investment company, is planning to exit its ownership in some key assets next year to realise and return cash to shareholders. According to a letter from chief executive Darragh Lyons that is going out to shareholders this morning, the company is exploring options to “monetise” its investments in 2021 to raise “significant cash” for payouts. “Where we determine that our investee companies have reached optimal value inflection points, we will seek to monetise our positions, and we expect to generate cash returns from our investee companies during 2021,...